Septerna Inc (SEPN)

• Market cap: $825M
• 1 day: -1.54%
• 5 days: -9.35%
• 1 month: -11.9%
• 3 months: 58.21%
• 6 months: 162.55%
• Year to date: -13.3%
• 1 year: -28.81%
• 5 years: -13.5%
• 10 years: -13.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

Employees: 75